Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating) was the target of a significant increase in short interest during the month of August. As of August 31st, there was short interest totalling 4,610,000 shares, an increase of 21.6% from the August 15th total of 3,790,000 shares. Currently, 5.6% of the shares of the stock are sold short. Based on an average daily volume of 708,900 shares, the days-to-cover ratio is currently 6.5 days.

Pediatrix Medical Group Stock Performance

Shares of NYSE MD traded up $0.41 during midday trading on Monday, hitting $17.99. 783,025 shares of the company's stock traded hands, compared to its average volume of 617,947. Pediatrix Medical Group has a 1 year low of $16.33 and a 1 year high of $29.48. The stock has a market capitalization of $1.52 billion, a price-to-earnings ratio of 17.94, a price-to-earnings-growth ratio of 1.14 and a beta of 1.88. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.39 and a current ratio of 1.39. The firm has a fifty day moving average of $20.42 and a 200 day moving average of $20.95.

Pediatrix Medical Group (NYSE:MD – Get Rating) last released its quarterly earnings results on Thursday, August 4th. The company reported $0.47 EPS for the quarter, beating the consensus estimate of $0.43 by $0.04. The firm had revenue of $486.00 million during the quarter, compared to analyst estimates of $491.54 million. Pediatrix Medical Group had a net margin of 4.30% and a return on equity of 16.15%. The business's revenue for the quarter was up 2.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.36 EPS. On average, analysts forecast that Pediatrix Medical Group will post 1.71 earnings per share for the current year.

Institutional Investors Weigh In On Pediatrix Medical Group

Analysts Set New Price Targets

Several research analysts recently commented on MD shares. Credit Suisse Group decreased their target price on shares of Pediatrix Medical Group from $30.00 to $28.00 and set an "outperform" rating on the stock in a research note on Thursday, August 11th. BMO Capital Markets decreased their target price on shares of Pediatrix Medical Group from $25.00 to $23.00 and set a "market perform" rating on the stock in a research note on Wednesday, August 10th. Four research analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $24.67.

Pediatrix Medical Group Company Profile

(Get Rating)

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

Read More

• Get a free copy of the StockNews.com research report on Pediatrix Medical Group (MD)
• Still Lovin' It: Investors Keep Visiting McDonald's
• Did FedEx Just Deliver A Buying Opportunity?
• Autozone Shifts Back Into Rally-Mode, New Highs Are In Sight
• Upwork Shares Stumble into Bargain Territory
• Kroger's is Your One-Stop Consumer Staples Stock

Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.